Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange

Scandinavian Journal of Rheumatology

Volumn 29, Issue 3, 2000, Pages 198-200

  Ferri, C ^a   Emdin, M ^a   Storino, F A A ^a   Giuggioli, D ^a   Longombardo, G ^a   Greco, F ^a   Fertig, N ^a   Medsger, T A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Plasma exchange; Pulmonary hypertension; Scleroderma; Systemic sclerosis; U3RNP antibody

Indexed keywords

RIBONUCLEOPROTEIN ANTIBODY;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CASE REPORT; DOPPLER ECHOGRAPHY; DYSPNEA; FEMALE; HUMAN; LUNG FUNCTION TEST; MYALGIA; PLASMAPHERESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCLERODERMA;

ADULT; AUTOANTIGENS; CHROMOSOMAL PROTEINS, NON-HISTONE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PLASMA EXCHANGE; SCLERODERMA, SYSTEMIC;

EID: 0034537993     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400750002120     Document Type: Article

References (15)

1. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis
2. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis
3. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
4. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: Association with serum anti-U3RNP antibody
5. Continuous intravenous epoprosterol versus conventional therapy in pulmonary hypertension due to the scleroderma spectrum of diseases: A 12-week multicenter, randomized controlled trial
6. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases
7. Autonomic disfunction in systemic sclerosis: Time and frequency domain 24 hour heart rate variability analysis
8. Plasma exchange in the treatment of progressive systemic sclerosis
9. Significance of plasma endothelin-1 levels in patients with systemic sclerosis
10. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs
11. Treatment of progressive systemic sclerosis by plasma exchange: Long-term results in 40 patients
12. Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis
13. Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis
14. Treatment of renal involvement in essential mixed cryoglobulinemia with prolonged Plasma Exchange
15. Noninvasive evaluation of cardiac dysrhythmias and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients